IRIS Accounts Production v24.3.2.46 SC719590 director 1.2.24 31.1.25 31.1.25 0 0 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWhSC7195902024-01-31SC7195902025-01-31SC7195902024-02-012025-01-31SC7195902023-01-31SC7195902023-02-012024-01-31SC7195902024-01-31SC719590ns15:Scotland2024-02-012025-01-31SC719590ns14:PoundSterling2024-02-012025-01-31SC719590ns10:Director12024-02-012025-01-31SC719590ns10:PrivateLimitedCompanyLtd2024-02-012025-01-31SC719590ns10:SmallEntities2024-02-012025-01-31SC719590ns10:AuditExempt-NoAccountantsReport2024-02-012025-01-31SC719590ns10:SmallCompaniesRegimeForDirectorsReport2024-02-012025-01-31SC719590ns10:SmallCompaniesRegimeForAccounts2024-02-012025-01-31SC719590ns10:FullAccounts2024-02-012025-01-31SC71959012024-02-012025-01-31SC719590ns10:RegisteredOffice2024-02-012025-01-31SC719590ns5:CurrentFinancialInstruments2025-01-31SC719590ns5:CurrentFinancialInstruments2024-01-31SC719590ns5:ShareCapital2025-01-31SC719590ns5:ShareCapital2024-01-31SC719590ns5:RetainedEarningsAccumulatedLosses2025-01-31SC719590ns5:RetainedEarningsAccumulatedLosses2024-01-31SC719590ns5:IntangibleAssetsOtherThanGoodwill2024-02-012025-01-31SC719590ns5:DevelopmentCostsCapitalisedDevelopmentExpenditure2024-02-012025-01-31SC719590ns5:ComputerEquipment2024-02-012025-01-31SC719590ns5:DevelopmentCostsCapitalisedDevelopmentExpenditure2024-01-31SC719590ns5:DevelopmentCostsCapitalisedDevelopmentExpenditure2025-01-31SC719590ns5:DevelopmentCostsCapitalisedDevelopmentExpenditure2024-01-31SC719590ns5:ComputerEquipment2024-01-31SC719590ns5:ComputerEquipment2025-01-31SC719590ns5:ComputerEquipment2024-01-31SC719590ns5:WithinOneYearns5:CurrentFinancialInstruments2025-01-31SC719590ns5:WithinOneYearns5:CurrentFinancialInstruments2024-01-31SC7195901ns10:Director12024-01-31SC7195901ns10:Director12023-01-31SC7195901ns10:Director12024-02-012025-01-31SC7195901ns10:Director12023-02-012024-01-31SC7195901ns10:Director12025-01-31SC7195901ns10:Director12024-01-31SC71959012024-02-012025-01-31
REGISTERED NUMBER: SC719590 (Scotland)











































The Borders Menopause Clinic Ltd

Unaudited Financial Statements

for the Year Ended 31st January 2025






The Borders Menopause Clinic Ltd (Registered number: SC719590)






Contents of the Financial Statements
for the year ended 31st January 2025




Page

Company information 1

Balance sheet 2

Notes to the financial statements 3 to 5


The Borders Menopause Clinic Ltd

Company Information
for the year ended 31st January 2025







Director: Mrs R C McCormick





Registered office: Whitsome Lea
Whitsome
Duns
Berwickshire
TD11 3NG





Registered number: SC719590 (Scotland)





Accountants: Rennie Welch LLP
Academy House
Shedden Park Road
Kelso
Roxburghshire
TD5 7AL

The Borders Menopause Clinic Ltd (Registered number: SC719590)

Balance Sheet
31st January 2025

2025 2024
Notes £    £    £    £   
Fixed assets
Intangible assets 4 516 688
Tangible assets 5 362 562
878 1,250

Current assets
Debtors 6 67,511 6,753
Cash at bank 14,349 1,157
81,860 7,910
Creditors
Amounts falling due within one year 7 18,122 4,316
Net current assets 63,738 3,594
Total assets less current liabilities 64,616 4,844

Capital and reserves
Called up share capital 100 100
Retained earnings 64,516 4,744
64,616 4,844

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st January 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st January 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of income and retained earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 4th March 2025 and were signed by:





Mrs R C McCormick - Director


The Borders Menopause Clinic Ltd (Registered number: SC719590)

Notes to the Financial Statements
for the year ended 31st January 2025

1. Statutory information

The Borders Menopause Clinic Ltd is a private company, limited by shares , registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.

2. Accounting policies

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover represents the total invoice value, excluding value added tax, of sales invoiced during the year, or the fair value of services provided for amounts not invoiced at the year end.

Turnover arising from the sale of goods is recognised when the significant risks and rewards of ownership have passed to the buyer. Turnover arising from the provision of services is recognised as contract activity progresses and the right to consideration is earned. Unbilled turnover is included in debtors as amounts recoverable on contracts.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Website costs are being amortised evenly over their estimated useful life of five years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life.
Office equipment - 25% on cost

Tangible fixed assets are stated at cost less accumulated depreciation and accumulated impairment losses.

Financial instruments
The following assets and liabilities are classified as financial instruments - trade debtors, accruals and directors' loans.

Directors' loans (being repayable on demand), trade debtors and accruals are measured at the undiscounted amount of the cash or other consideration expected to be paid or received.

Financial assets that are measured at amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in the Statement of Income and Retained Earnings.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


The Borders Menopause Clinic Ltd (Registered number: SC719590)

Notes to the Financial Statements - continued
for the year ended 31st January 2025

2. Accounting policies - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Provisions
Provisions are set up only where it is probable that a present obligation exists as a result of an event prior to the balance sheet date and that a payment will be required in settlement that can be estimated reliably. Where material, provisions are calculated on a discounted basis.

Going concern
The director has considered the company's financial position for a minimum of 12 months and beyond from the date of signing these financial statements and has an expectation that the company should be in a position to continue trading in the current format for the foreseeable future. Accordingly, she continues to adopt the going concern basis in preparing these financial statements.

3. Employees and directors

The average number of employees during the year was NIL (2024 - NIL).

4. Intangible fixed assets
Website
costs
£   
Cost
At 1st February 2024
and 31st January 2025 860
Amortisation
At 1st February 2024 172
Amortisation for year 172
At 31st January 2025 344
Net book value
At 31st January 2025 516
At 31st January 2024 688

The Borders Menopause Clinic Ltd (Registered number: SC719590)

Notes to the Financial Statements - continued
for the year ended 31st January 2025

5. Tangible fixed assets
Office
equipment
£   
Cost
At 1st February 2024
and 31st January 2025 801
Depreciation
At 1st February 2024 239
Charge for year 200
At 31st January 2025 439
Net book value
At 31st January 2025 362
At 31st January 2024 562

6. Debtors: amounts falling due within one year
2025 2024
£    £   
Trade debtors 8,166 3,589
Other debtors 59,345 3,164
67,511 6,753

7. Creditors: amounts falling due within one year
2025 2024
£    £   
Taxation and social security 17,122 916
Other creditors 1,000 3,400
18,122 4,316

8. Director's advances, credits and guarantees

The following advances and credits to a director subsisted during the years ended 31st January 2025 and 31st January 2024:

2025 2024
£    £   
Mrs R C McCormick
Balance outstanding at start of year - -
Amounts advanced 69,378 -
Amounts repaid (12,927 ) -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 56,451 -

9. Post balance sheet events

Since the year end a final dividend was declared on 28th February 2025 at £367.00 per share.